Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced liver diseases.

D Larrey1

  • 1Service d'Hépatogastro-entérologie et Transplantation hépatique, Hôpital Saint-Eloi, Montpellier, France. d-larrey@chu-montpellier.fr

Journal of Hepatology
|March 23, 2000
PubMed
Summary

Drug-induced liver injuries present diagnostic challenges, often mimicking other conditions. Physicians should consider drug hepatotoxicity in older patients with multiple medications, especially after ruling out viral causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

Alimentary pharmacology & therapeutics·2017
Same author

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

The Journal of frailty & aging·2016
Same author

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients.

Journal of viral hepatitis·2015
Same author

Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Case definition and phenotype standardization in drug-induced liver injury.

Clinical pharmacology and therapeutics·2011
Same author

[Anicteric cholestasis revealing schistosomiasis at a distance from the infection site].

Medecine tropicale : revue du Corps de sante colonial·2011

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver injury (DILI) is a significant clinical challenge with diverse presentations, predominantly acute hepatitis.
  • Diagnosis is often difficult due to non-specific signs and reliance on excluding other causes.
  • Hepatotoxicity is a critical concern for pharmaceutical development and patient safety.

Purpose of the Study:

  • To highlight the diagnostic complexities of drug-induced liver injuries.
  • To emphasize the severity and potential long-term consequences of DILI, including fulminant hepatitis and cirrhosis.
  • To underscore the importance of avoiding re-administration of causative agents and related drugs.

Main Methods:

  • Clinical case review and analysis of diagnostic challenges in drug-induced liver injury.
  • Literature review on the presentation, diagnosis, and management of DILI.
  • Discussion of cross-hepatotoxicity and implications for drug development.

Main Results:

  • Acute hepatocellular hepatitis is a common and severe manifestation of DILI.
  • Diagnosis requires exclusion of other causes, particularly in patients over 50 taking multiple drugs.
  • Cross-hepatotoxicity necessitates caution with structurally related drugs.

Conclusions:

  • Improved prediction of drug hepatotoxicity is crucial, especially for drugs with concerning chemical structures or from known hepatotoxic classes.
  • Physicians must maintain a high index of suspicion for DILI in at-risk populations.
  • Avoiding re-exposure to the offending agent and related compounds is essential for patient recovery.

Related Experiment Videos